Estia Health (ASX:EHE) - Aktienkurs, Nachrichten und Analyse

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

EHE Aktienübersicht

Estia Health Limited provides residential aged care home services in Australia.

Über das Unternehmen

EHE grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	4/6
Künftiges Wachstum	4/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	3/6
Dividenden	2/6

Belohnungen

59% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 66.96% pro Jahr

Risikoanalyse

Die Dividende von 5.1% ist durch die Erträge nicht gut gedeckt

Estia Health Limited Wettbewerber

Monash IVF Group

ASX:MVF

AU$459.8m

Regis Healthcare

ASX:REG

AU$1.9b

Pacific Smiles Group

ASX:PSQ

AU$293.6m

Ramsay Health Care

ASX:RHC

AU$9.5b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Estia Health
Historische Aktienkurse
Aktueller Aktienkurs	AU$3.08
52-Wochen-Hoch	AU$3.14
52-Wochen-Tief	AU$1.93
Beta	0.96
11 Monat Veränderung	0.98%
3 Monate Veränderung	1.99%
1 Jahr Veränderung	57.95%
33 Jahre Veränderung	77.01%
5 Jahre Veränderung	41.28%
Veränderung seit IPO	-35.02%

Aktuelle Nachrichten und Updates

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

Aktionärsrenditen

	EHE	AU Healthcare	AU Markt
7D	0%	0.7%	0.3%
1Y	57.9%	-7.3%	15.1%

Rendite im Vergleich zur Industrie: EHE übertraf die Branche Australian Healthcare , die im vergangenen Jahr eine Rendite von -20.5 erzielte.

Rendite vs. Markt: EHE übertraf den Markt Australian, der im vergangenen Jahr eine Rendite von 9.6 erzielte.

Preisvolatilität

Is EHE's price volatile compared to industry and market?
EHE volatility
EHE Average Weekly Movement	0.6%
Healthcare Industry Average Movement	4.9%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	16.6%
10% least volatile stocks in AU Market	3.6%

Stabiler Aktienkurs: EHE hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: EHEDie wöchentliche Volatilität (1%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2005	8,220	Sean Bilton	www.estiahealth.com.au

Estia Health Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Estia Health im Vergleich zum Marktanteil des Unternehmens?
EHE grundlegende Statistiken
Marktanteil	AU$805.54m
Gewinn(TTM)	-AU$33.90m
Umsatz(TTM)	AU$754.30m

1.1x

Kurs-Umsatz-Verhältnis

-23.8x

Kurs-Gewinn-Verhältnis

Ist EHE zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
EHE Gewinn- und Verlustrechnung (TTM)
Einnahmen	AU$754.30m
Kosten der Einnahmen	AU$584.82m
Bruttogewinn	AU$169.48m
Sonstige Ausgaben	AU$203.37m
Umsatz	-AU$33.90m

Zuletzt gemeldete Gewinne

Jun 30, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.13
Bruttomarge	22.47%
Nettogewinnspanne	-4.49%
Schulden/Eigenkapital-Verhältnis	14.0%

Wie hat sich EHE auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

5.1%

Aktuelle Dividendenrendite

-120%

Ausschüttungsquote

This company listing is no longer active

EHE Aktienübersicht

Belohnungen

Risikoanalyse

Estia Health Limited Wettbewerber

ASX:MVF

AU$459.8m

ASX:REG

AU$1.9b

ASX:PSQ

AU$293.6m

ASX:RHC

AU$9.5b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Erträge & Einnahmen